PremiumZBIO

The CEO put $1.6 million on the table: is ZBIO the bet for 2026 or just another pipe dream?

ZBIO's CEO purchased company stocks in the open market for $1.6 million, indicating deep confidence ahead of critical clinical catalysts in 2026.

By the SpyStocks desk · 7mo ago · 3 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Telegram@TheAmericanDream5

Real-time buys, sweeps, and trading halts from the desk. Free to join.